Evidence map›Paper›PMID 38598830›Full record

ArticleInternational braz j urol : official journal of the Brazilian Society of Urology

Clinical safety and efficacy of microwave ablation for small renal masses.

Ashley Foret, Christopher B Haaga, Shivani Jain, Chelsea O Baumgartner, Megan Escott, Benjamin R Henderson, Sean T O'Brien, Scott E Delacroix, Jessie R R Gills, Mary E Westerman

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Management of Small Renal Masses: Literature and Guidelines Review.International braz j urol : official journal of the Brazilian Society of Urology
    Review
  6. MRI and biopsy in prostate cancer are the hot topic in this number of International Brazilian Journal of Urology.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ashley ForetSchool of Medicine, LSU Health Science Center New Orleans, New Orleans, Louisiana, USA.
Christopher B HaagaSchool of Medicine, LSU Health Science Center New Orleans, New Orleans, Louisiana, USA.
Shivani JainSchool of Medicine, LSU Health Science Center New Orleans, New Orleans, Louisiana, USA.
Chelsea O BaumgartnerDepartment of Urology, LSU Health Science Center, New Orleans, Louisiana, USA.
Megan EscottSchool of Medicine, LSU Health Science Center New Orleans, New Orleans, Louisiana, USA.
Benjamin R HendersonDepartment of Radiology, East Jefferson General Hospital, Metairie, Louisiana, USA.
Sean T O'BrienDepartment of Radiology, East Jefferson General Hospital, Metairie, Louisiana, USA.
Scott E DelacroixDepartment of Urology, LSU Health Science Center, New Orleans, Louisiana, USA.
Jessie R R GillsDepartment of Urology, LSU Health Science Center, New Orleans, Louisiana, USA.
Mary E WestermanDepartment of Radiology, East Jefferson General Hospital, Metairie, Louisiana, USA.
Louisiana State University Health Sciences Center New Orleans · USEast Jefferson General Hospital · USWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCT-guided MWA is a safe and effective tool that should be utilized in the treatment of small renal masses (SRMs). We aim to clarify the utility of CT-guided MWA by examining patient outcomes such as recurrence, treatment success, changes in renal function, and complications.

methodsA retrospective review of consecutive patients with SRMs who underwent same day renal mass biopsy (RMB) and CT-guided MWA between 2015 and 2022 was performed. Treatment safety was assessed by 30-day complications according to the Clavien-Dindo system and change in eGFR >30 days post-procedure. Treatment efficacy was defined by local recurrence and incomplete treatment rates and calculated using the Kaplan-Meier method.

resultsA total of 108 renal masses were found in 104 patients. The overall complication rate was 7.4% (8/108), of which 4 were major complications (3.7%). For those with renal function available >30 days post ablation, the median eGFR was 47.2 (IQR: 36.0, 57), compared to 52.3 (IQR: 43.7, 61.5) pre-ablation, p<0.0001. 5-year local recurrence free survival was 86%. Among those with biopsy proven malignancy (n= 66), there were five local recurrences (7.54%) occurring at a median of 25.1 months (IQR 19.9, 36.2) and one case (1.5%) of incomplete treatment.

conclusionsAs the medical field continues to evolve towards less invasive interventions, MWA offers a valuable tool in the management of renal masses. With low major complication and recurrence rates, our findings support the utility of CT-guided MWA as a tool for treatment of SRMs.

Indexed as

Ablation TechniquesCarcinoma, Renal CellCatheter AblationKidney NeoplasmsHumansMicrowavesRetrospective StudiesTreatment OutcomeKidney NeoplasmsRadiofrequency AblationTransurethral Resection of Prostate

Identifiers

PMID38598830
PMCPMC11152331
OpenAlexW4394762597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.